Harfst & Associates, Inc. Becton Dickinson & CO Transaction History

Harfst & Associates, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$230.58 - $256.08 $208,444 - $231,496	-904 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$217.4 - $246.08 $4,782 - $5,413	-22 Reduced 2.38%	904 $227,000
Q1 2019 May 01, 2019	BUY	$206.05 - $248.17 $7,417 - $8,934	36 Added 4.04%	926 $231,000
Q4 2018 Feb 06, 2019	BUY	$204.73 - $257.93 $4,504 - $5,674	22 Added 2.53%	890 $200,000
Q3 2018 Oct 31, 2018	BUY	$233.07 - $256.0 $6,525 - $7,168	28 Added 3.33%	868 $226,000
Q2 2018 Aug 10, 2018	BUY	$208.1 - $233.85 $174,804 - $196,434	840 New	840 $201,000
Q1 2018 May 07, 2018	SELL	$205.46 - $240.27 $230,115 - $269,102	-1,120 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$189.0 - $222.64 $211,680 - $249,356	1,120 New	1,120 $239,000
Q3 2017 Nov 07, 2017	SELL	$186.89 - $198.9 $130,262 - $138,633	-697 Closed	0 $0
Q2 2017 Aug 11, 2017	BUY	N/A	697	697 $135,000

1,799

260M

1.28M

1.12M

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Harfst & Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Harfst & Associates, Inc. with notifications on news.